Bruker (NASDAQ: BRKR) reported Q4 EPS of $0.59, $0.06 worse than the analyst estimate of $0.65. Revenue for the quarter came in at $977.2 million versus the consensus estimate of $959.08 million.

GUIDANCE:

Bruker sees FY2026 EPS of $2.10-$2.15, versus the consensus of $2.14. Bruker sees FY2026 revenue of $3.57-3.6 billion, versus the consensus of $3.48 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.